Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 2
Submit an article Journal homepage
11
Views
1
CrossRef citations to date
0
Altmetric
Articles

Carcinoid heart disease: Case and literature review

Michiel DumouleinDepartment of Cardiology, University Hospitals Leuven, Leuven, Belgium.
, MD,
Chris VerslypeDepartment of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
, MD, PhD,
Eric Van CutsemDepartment of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
, MD, PhD,
Bart MeurisDepartment of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium.
, MD, PhD,
Paul HerijgersDepartment of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium.
, MD, PhD,
Willem FlamengDepartment of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium.
, MD, PhD &
Marie-Christine HerregodsDepartment of Cardiology, University Hospitals Leuven, Leuven, Belgium.
, MD, PhD show all
Pages 261-264 | Received 20 Jan 2010, Published online: 23 May 2017

References

  • Modlin IM, Sandor A. An analysis of 8305 cases of carci-noid tumors. Cancer 1997; 79: 813–29.
  • Fox DJ, Khattar RS. Carcinoid heart disease: presentation, diagnosis and management. Heart 2004; 90: 1224–8.
  • Westberg G, Wangberg B, Ahlman H, Bergh CH, Beckman-Suurkula M, Caidahl K. Prediction of prognosis by echocar-diography in patients with midgut carcinoid syndrome. Br J Surg 2001; 88: 865–72.
  • Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188–97.
  • Connolly HM, Schaff HV, Mullany CJ, Rubin J, Abel MD, Pellikka PA. Surgical management of left-sided carcinoid heart disease. Circulation 2001; 104: I-36-1–40.
  • Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E. Carcinoid heart disease: relationship of circu-lating vasoactive substances to ultrasound-detectable car-diac abnormalities. Circulation 1988; 77: 264–9.
  • Pandya U, Pellikka P, Enriquez-Sarano M, Edwards WD, Schaff HV, Connolly HM. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. J Am Coll Cardiol 2002; 40: 1328–32.
  • Simula DV, Edwards WD, Tazelaar HD, Connolly HM, Schaff HV. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc 2002; 77: 139–47.
  • Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnor-malities detected by cardiac catheterization and echocardio-graphy. Circulation 1995; 92: 790–5.
  • Zuetenhorst JM, Bonfrer JM, Korse CM, Bakker R, van Tinteren H, Taal BG. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer 2003; 97: 1609–15.
  • Connolly H, Crary J, McGoon M, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease asso-ciated with fenfluramine-phentermine. N Engl J Med 1997; 337; 581–8.
  • Zanettini, R, Antonini, A, Gatto, G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 2007; 356: 39–46.
  • Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgita-tion. N Engl J Med 2007; 356: 29–38.
  • Gustafsson B, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, Solligard E, Fossmark R, Bakke I, Syversen U, Waldum H. Long-term serotonin administration induces heart valve disease in rats. Circulation 2005; 111: 1517–22.
  • Denney WD, Kemp WE Jr, Anthony LB, Oates JA, Byrd BF 3rd. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol 1998; 32: 1017–22.
  • Connolly HM, Nishimura RA, Smith HC, Pellikka PA, Mullany CJ, Kvols LK. Outcome of cardiac surgery for car-cinoid heart disease. J Am Coll Cardiol 1995; 25: 410–6.
  • Moller JE, Pellikka PA, Bernheim AM, Schaff HV, Rubin J, Connolly HM. Prognosis of carcinoid heart disease: analy-sis of 200 cases over two decades. Circulation 2005; 112: 3320–7.
  • Ridker PM, Chertow GM, Karlson EW, Neish AS, Schoen FJ. Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease. Am Heart J1991; 121: 1835–8.
  • Schoen FJ, Hausner RJ, Howell JF, Beazley HL, Titus JL. Porcine heterograft valve replacement in carcinoid heart disease. J Thorac Cardiovasc Surg 1981; 81: 100–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.